Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming "collateral effect"
- PMID: 33130024
- PMCID: PMC7598418
- DOI: 10.1016/j.jgar.2020.10.004
Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming "collateral effect"
Abstract
- •
COVID-19 patients have an exaggerated risk of acquiring BSI during ICU stay.
- •
The incidence of ICU-acquired BSI in COVID-19 patients is higher than that reported in European ICUs in the pre-COVID-19 period.
- •
The commonest aetiological agents of BSI were intestinal commensals.
- •
A high rate of acquisition of VRE colonisation was observed.
References
-
- Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed: interim guidance. World Health Organization. Available at https://www.who.int/publications/i/item/10665-331495
-
- Siegel J.D., Rhinehart E., Jackson M., Chiarello L. Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35:S165–S193. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources